Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 3
2015 4
2017 1
2018 3
2019 2
2020 3
2021 3
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean xavier palardy (2 results)?
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, de Baere T, Assenat E, Tacher V, Robert C, Terroir-Cassou-Mounat M, Mariano-Goulart D, Amaddeo G, Palard X, Hollebecque A, Kafrouni M, Regnault H, Boudjema K, Grimaldi S, Fourcade M, Kobeiter H, Vibert E, Le Sourd S, Piron L, Sommacale D, Laffont S, Campillo-Gimenez B, Rolland Y; DOSISPHERE-01 Study Group. Garin E, et al. Among authors: palard x. Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29. doi: 10.1016/S2468-1253(20)30290-9. Epub 2020 Nov 7. Lancet Gastroenterol Hepatol. 2021. PMID: 33166497 Free article. Clinical Trial.
Trans-arterial Radioembolization Dosimetry in 2022.
Garin E, Guiu B, Edeline J, Rolland Y, Palard X. Garin E, et al. Among authors: palard x. Cardiovasc Intervent Radiol. 2022 Nov;45(11):1608-1621. doi: 10.1007/s00270-022-03215-x. Epub 2022 Aug 18. Cardiovasc Intervent Radiol. 2022. PMID: 35982334 Review.
Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial.
Garin E, Tselikas L, Guiu B, Chalaye J, Rolland Y, de Baere T, Assenat E, Tacher V, Palard X, Déandreis D, Mariano-Goulart D, Amaddeo G, Boudjema K, Hollebecque A, Meerun MA, Regnault H, Vibert E, Campillo-Gimenez B, Edeline J. Garin E, et al. Among authors: palard x. J Nucl Med. 2024 Feb 1;65(2):264-269. doi: 10.2967/jnumed.123.266211. J Nucl Med. 2024. PMID: 38212068 Free PMC article. Clinical Trial.
18F-FDG PET/CT-Based Prognostic Survival Model After Surgery for Head and Neck Cancer.
Creff G, Jegoux F, Palard X, Depeursinge A, Abgral R, Marianowski R, Leclere JC, Eugene T, Malard O, Crevoisier R, Devillers A, Castelli J. Creff G, et al. Among authors: palard x. J Nucl Med. 2022 Sep;63(9):1378-1385. doi: 10.2967/jnumed.121.262891. Epub 2021 Dec 9. J Nucl Med. 2022. PMID: 34887336 Free PMC article.
Asymmetric muscle activity on (18)F-FDG PET/CT.
Palard X, Carai S, Le Roux PY, Salaün PY, Abgral R. Palard X, et al. Clin Nucl Med. 2015 Jun;40(6):e336-7. doi: 10.1097/RLU.0000000000000735. Clin Nucl Med. 2015. PMID: 25706792
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation.
Theysohn JM, Demircioglu A, Kleditzsch M, Ludwig JM, Weber M, Umutlu L, Li Y, Kircher M, Lapa C, Buck A, Koehler M, Wildgruber M, Lange CM, Palard X, Garin E, Herrmann K, Forsting M, Nensa F. Theysohn JM, et al. Among authors: palard x. Sci Rep. 2022 Dec 1;12(1):20718. doi: 10.1038/s41598-022-25077-6. Sci Rep. 2022. PMID: 36456637 Free PMC article.
20 results